- Rollins 2Q Revenue: $891.9 million, up 8.7% compared to the same period last year.
- Revenue Estimate: Expected revenue was $897.1 million.
- EPS (Earnings Per Share): 27 cents, compared to 22 cents in the previous year.
- Cash and Cash Equivalents: $106.7 million, down 31% year-over-year.
- Cash Estimate: Expected cash and cash equivalents were $177.2 million.
- Adjusted EPS: 27 cents.
- Analyst Ratings: 5 buys, 5 holds, and 1 sell.
A look at Rollins Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Rollins Inc, the pest control services provider, has a promising long-term outlook based on the Smartkarma Smart Scores analysis. With above-average scores in Growth and Momentum, the company shows strong potential for expansion and market performance. Its Resilience score also indicates a stable foundation amidst challenges, providing investors with confidence in its ability to navigate uncertainties. While the Value and Dividend scores are moderate, the higher ratings in other key factors bode well for Rollins Inc‘s future prospects.
Rollins, Inc., known for its essential pest control services through subsidiary Orkin Exterminating Company, Inc., operates in the United States, Canada, and Mexico. The company’s focus on protecting against termite damage, rodents, and insects highlights its commitment to maintaining healthy environments for its customers. The above-average scores in Growth and Momentum, coupled with a solid Resilience rating, position Rollins Inc as a promising player in the pest control industry for the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
